Trial intelligence / Profile preview

Beta-blocker treatment after acute myocardial infarction without heart failure

2018-000590-75Phase 4Completed

Sponsor
Oslo University Hospital
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of carvedilol in myocardial infarction (MI) (2 arms), sponsored by Oslo University Hospital. Started Mar 2018; status: completed.

02

Drugs

carvedilol
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on 2018-000590-75.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-000590-75.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call